Sign inJoin waitlistJoin the waitlist

David Baskin

Program Director, Neurosurgery · Houston Methodist Hospital

Credentials: · · · ·

History

Neurosurgery · Houston Methodist Hospital
Present
Houston Methodist Hospital
Present
Skull Base Tumor Initiative · Houston Methodist Hospital
Present

University of California-San Francisco
1978–1984
Icahn School of Medicine at Mount Sinai
1974–1978
Swarthmore College

Research

A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study
New England Journal of Medicine · 1990 · 2,039 citations
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial
JAMA Oncology · 2017 · 747 citations
Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study
Journal of neurosurgery · 1992 · 508 citations

RS
Richard Simpson
9 papers · 6 as a resident
Bin Teh
8 papers
Suzanne Powell
6 papers
Andrew Lee
5 papers
Amanda Jenson
4 papers · 4 as a fellow
Brian Butler
4 papers
Gavin Britz
4 papers
Matthew Cykowski
4 papers
PN
Pamela New
4 papers
RG
Robert Grossman
4 papers
Sean Barber
4 papers · 4 as a resident
Todd Trask
4 papers

Grants

In situ Ligation for Detection of Specific Dna Damage
National Cancer Institute · R01
Contact PI · $309.2K · Baylor College of Medicine
1998–2002

Clinical trials

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Principal investigator · Recruiting · Phase 1, Phase 2
The Methodist Hospital Research Institute
2018–2026
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
Principal investigator · Recruiting · Phase 1, Phase 2
David Baskin MD
2017–2026